Sheldon L. Koenig - 07 Mar 2023 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
President and CEO, Director
Signature
/s/ Sheldon L. Koenig
Issuer symbol
ESPR
Transactions as of
07 Mar 2023
Net transactions value
-$27,510
Form type
4
Filing time
08 Mar 2023, 15:21:24 UTC
Previous filing
20 Sep 2022
Next filing
15 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale $27,510 -5,441 -2.7% $5.06 194,815 07 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on vested shares of performance-based restricted stock units.
F2 Consists of 194,815 shares of common stock held, including 1,999 shares recently acquired in Esperion's Employee Stock Purchase Plan.